Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
Medtronic
Accenture
Deloitte
US Department of Justice
McKinsey
Cantor Fitzgerald
Chubb

Generated: August 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206863

« Back to Dashboard

NDA 206863 describes DALFAMPRIDINE, which is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, and Aurobindo Pharma Ltd, and is included in three NDAs. It is available from one supplier. Additional details are available on the DALFAMPRIDINE profile page.

The generic ingredient in DALFAMPRIDINE is dalfampridine. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dalfampridine profile page.
Summary for 206863
Tradename:DALFAMPRIDINE
Applicant:Accord Hlthcare
Ingredient:dalfampridine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Jul 11, 2018TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Farmers Insurance
Harvard Business School
Julphar
Fuji
Cantor Fitzgerald
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.